Skip to content

Clinical trials

Genetic Diseases, Inborn trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: United Kingdom Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20094
20101
20113
20121
20132
20143
20152
20164
20173
201811
20196
20202
20218
20227
20235
20245
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Recruiting14
Active, not recruiting8
Terminated8
Enrolling by invitation7
Unknown status2
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical10
QED Therapeutics, a BridgeBio company7
Vertex Pharmaceuticals Incorporated7
GenSight Biologics4
ModernaTX, Inc.4
Novartis Pharmaceuticals4
Alexion Pharmaceuticals, Inc.3
Novo Nordisk A/S3
CSL Behring2
Forma Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn84
Musculoskeletal Diseases19
Nervous System Diseases19
Hematologic Diseases16
Metabolism, Inborn Errors15
Metabolic Diseases13
Bone Diseases12
Osteochondrodysplasias12
Blood Coagulation Disorders10
Coagulation Protein Disorders10

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.